Monoamine Oxidase Inhibitors and Tricyclic Antidepressants
作者： Terry J. Danielson
DOI: 10.1007/978-1-59259-654-6_4
关键词:
摘要: Depression is a disorder consisting, in varying degrees, of low mood, pessimism, lethargy, and loss interest former pleasures. Treatment this disability frequently involves the use drugs such as monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), and, more recently, selective serotonin reuptake (SSRIs). These have multiple pharmacological toxicological properties are capable producing severe effects independent antidepressant response.
springer.com
sci-hub.st 参考文章(180)
B. Browne, S. Linter, Monoamine oxidase inhibitors and narcotic analgesics. A critical review of the implications for treatment. British Journal of Psychiatry. ,vol. 151, pp. 210- 212 ,(1987) , 10.1192/BJP.151.2.210
Urs A. Meyer, Ulrich M. Zanger, Molecular mechanisms of genetic polymorphisms of drug metabolism. Annual Review of Pharmacology and Toxicology. ,vol. 37, pp. 269- 296 ,(1997) , 10.1146/ANNUREV.PHARMTOX.37.1.269
Kim Brøsen, Tanja Zeugin, Urs A Meyer, Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine Clinical Pharmacology and Therapeutics. ,vol. 49, pp. 609- 617 ,(1991) , 10.1038/CLPT.1991.77
Annakatri Ohberg, Erkki Vuori, Timo Klaukka, Jouko Lonnqvist, Antidepressants and suicide mortality. Journal of Affective Disorders. ,vol. 50, pp. 225- 233 ,(1998) , 10.1016/S0165-0327(98)00114-1
Henrik Druid, Per Holmgren, Björn Carlsson, Johan Ahlner, Cytochrome P450 2D6 (CYP2D6) genotyping on postmortem blood as a supplementary tool for interpretation of forensic toxicological results. Forensic Science International. ,vol. 99, pp. 25- 34 ,(1999) , 10.1016/S0379-0738(98)00169-8
G W Kerr, Tricyclic antidepressant overdose: a review. Emergency Medicine Journal. ,vol. 18, pp. 236- 241 ,(2001) , 10.1136/EMJ.18.4.236
E. Martin Caravati, Philip J. Bossart, Demographic and electrocardiographic factors associated with severe tricyclic antidepressant toxicity Clinical Toxicology. ,vol. 29, pp. 31- 43 ,(1991) , 10.3109/15563659109038595
O. Spigset, K. Hedenmalm, M.-L. Dahl, B.-E. Wiholm, R. Dahlqvist, Seizures and myoclonus associated with antidepressant treatment : assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors Acta Psychiatrica Scandinavica. ,vol. 96, pp. 379- 384 ,(1997) , 10.1111/J.1600-0447.1997.TB09933.X
Karthik Venkatakrishnan, David J. Greenblatt, Lisa L. von Moltke, Jürgen Schmider, Jerold S. Harmatz, Richard I. Shader, Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4. The Journal of Clinical Pharmacology. ,vol. 38, pp. 112- 121 ,(1998) , 10.1002/J.1552-4604.1998.TB04399.X
Jess Amchin, Larry Ereshefsky, William Zarycranski, Karen Taylor, Dominick Albano, Patricia M. Klockowski, Effect of Venlafaxine versus Fluoxetine on Metabolism of Dextromethorphan, a CYP2D6 Probe The Journal of Clinical Pharmacology. ,vol. 41, pp. 443- 451 ,(2001) , 10.1177/00912700122010159